State of Tennessee, Department of Treasury
Position in NBIX — Neurocrine Biosciences Inc
CIK 1587973
NASHVILLE, TN
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,453,734
-$341,112 QoQ
Shares Held
33,807
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026State of Tennessee, Department of Treasury holds $84,473,213 across 20 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,021,086 | $30,755,110 | |
| 2 | ZTS |
Zoetis Inc.
|
148,537 | $17,558,558 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,255 | $10,824,849 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
192,658 | $4,610,305 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
33,807 | $4,453,734 | |
| 6 | VTRS |
Viatris Inc
|
234,477 | $3,167,784 | |
| 7 | ALKS |
Alkermes plc.
|
66,936 | $2,366,856 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
30,744 | $2,331,932 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,453,734 | 33,807 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,794,846 | 33,807 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $4,949,096 | 35,255 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,429,556 | 43,198 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,777,698 | 43,198 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,896,527 | 43,198 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,117,726 | 44,417 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,689,763 | 41,329 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,791,536 | 41,992 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,191,665 | 46,992 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,871,600 | 52,192 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,096,674 | 43,443 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,397,300 | 43,443 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,527,563 | 46,279 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,853,192 | 36,279 | Shares | Sole | 2023-01-26 | |
| 2022-06-30 | $3,281,176 | 33,660 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,968,125 | 63,660 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $5,421,922 | 63,660 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $6,105,630 | 63,660 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,812,400 | 70,000 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||